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Background: Pierre Robin sequence (PRS) is a condition present at birth. It is characterized by micrognathia, cleft
palate, upper airway obstruction, and feeding problems. Multiple etiologies including genetic defects have been
documented in patients with syndromic, non-syndromic, and isolated PRS.
Case presentation: We report a 4-year-old boy with a complex small supernumerary marker chromosome (sSMC)
who had non-syndromic Pierre Robin sequence (PRS). The complex marker chromosome, der(14)t(14;16)(q11.2;p13.13),
was initially identified by routine chromosomal analysis and subsequently characterized by array-comparative genomic
hybridization (array CGH) and confirmed by fluorescence in situ hybridization (FISH). Clinical manifestations included
micrognathia, U-type cleft palate, bilateral congenital ptosis, upslanted and small eyes, bilateral inguinal hernias,
umbilical hernia, bilateral clubfoot, and short fingers and toes. To our best knowledge, this was the first case diagnosed
with non-syndromic PRS associated with a complex sSMC, which involved a 3.8 Mb gain in the 14q11.2 region and an
11.8 Mb gain in the 16p13.13-pter region.
Conclusions: We suggest that the duplicated chromosome segment 16p13.3 possibly may be responsible for the
phenotypes of our case and also may be a candidate locus of non-syndromic PRS. The duplicated CREBBP gene within
chromosome 16p13.3 is associated with incomplete penetrance regarding the mandible development anomalies.
Further studies of similar cases are needed to support our findings.
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The Pierre Robin sequence (PRS) is characterized by
micrognathia, cleft palate, upper airway obstruction, and
feeding problems [1]. The prevalence of PRS is estimated
to be 1 in 8,500-14,000 births in the general population
[2,3]. The ratio between male and female is equal [3,4].
Approximately 25% of PRS diagnosed in patients is asso-
ciated with a known syndrome, 35% of patients have
other abnormalities that do not constitute a recognizable
syndrome (non-syndromic), and the remaining 40% of
patients present with an isolated manifestation of PRS* Correspondence: shibo-li@ouhsc.edu
†Equal contributors
1Department of Pediatrics, University of Oklahoma Health Sciences Center,
Oklahoma City, OK 73104, USA
Full list of author information is available at the end of the article
© 2014 Sun et al.; licensee BioMed Central Ltd
Commons Attribution License (http://creativec
reproduction in any medium, provided the or
Dedication waiver (http://creativecommons.or
unless otherwise stated.[5-7]. Although the first PRS case was described in 1923
[8], the pathogenic mechanism of PRS remains unclear.
Embryologically, micrognathia is believed to be the pri-
mary defect which triggers a sequence of events includ-
ing glossoptosis, with or without cleft palate. In theory,
etiologies such as alcohol abuse during pregnancy, envir-
onmental factors, and hereditary factors resulting in
micrognathia early in development can lead to PRS [9].
Mechanical obstructions including uterine compression,
oligohydramnios, and fibroids may be related to abnormal
mandibular growth [6,10-12]. Specific gene mutations and
chromosomal anomalies including translocations, dele-
tions, and duplications have also been documented in pa-
tients with syndromic, non-syndromic, and isolated PRS.
We report a boy with non-syndromic PRS due to a
small supernumerary marker chromosome (sSMC). The. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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part of the long arm of chromosome 14 (14q11.2) and
the terminal region of the short arm of chromosome 16
(16pter-p13.13), which led to duplications of these two
chromosomal regions. To the best of our knowledge,
this is the first report of a patient with PRS and a sSMC.
Case presentation
The proband was the first child born to healthy non-
consanguineous parents (maternal age 19 years) at a gesta-
tional age of 38 weeks. Physical examination at birth
showed micrognathia, U-type cleft palate, bilateral congeni-
tal ptosis, upslanted and small eyes, bilateral inguinal her-
nias, umbilical hernia, bilateral clubfoot, and short fingers
and toes. These features are consistent with clinical fea-
tures of non-syndromic PRS. At the age of 4.5 months, he
showed significant developmental delay. At 5 months old,
he underwent bilateral inguinal hernia repair. At the age of
13 months, he had bilateral frontalis suspension surgeries.
Five months later, he underwent a bilateral mandibular
ramus osteotomy, a bilateral mandibular distraction using
an external multiplanar device via intraoral incisions, and
mandibular distraction device placement. At the age of
24 months, his clubfoot was treated with ponseti casting.
The family history was noncontributory. His mother was
not exposed to secondhand smoke or infectious diseases
and denied alcohol or drugs abuse in pregnancy.
Results
G-banding of chromosomes derived from the peripheral
blood showed that each of the 21 cells analyzed had a
modal number of 47 chromosomes including one X and
one Y chromosome and a small supernumerary marker
chromosome of unknown chromosomal origin. Based on
the morphology, this marker chromosome appeared to
be derived from one of the acrocentric chromosomes,
but the size was smaller than chromosome 21 (Figure 1).
Array CGH is the current standard assay used to de-
termine the chromosomal origin and the genomic size
of non-mosaic chromosomal imbalances such as this
case. Unexpectedly, array CGH showed two different
chromosomal segment gains: the first was the gain of
14q11.2 region with 3.8 Mb (19,694,999-23,534,999) and
the second one was the gain of 16p13.13-pter region
with 11.8 Mb (14,999-11,834,999) (GRCh36/hg18, UCSC
Genome Browser, February 2006 Assembly) (Figure 2).
To confirm that the two chromosomal segments, 14q11.2
and 16pter-p13.13, were indeed joined together to form
the marker chromosome, confirmatory FISH testing, util-
izing the centromeric probe 14/22 (red) and the TelVysion
16p probe (green) specific for 16pter, was performed. All
the metaphase cells analyzed showed that the marker
chromosome had both the centromeric signal of chromo-
some 14/22 (red color) and the subtelomeric signal of16pter (green color) indicating this marker chromosome
was indeed derived from the unbalanced translocation be-
tween chromosomes 14 and 16, der(14)t(14;16)(q11.2;
p13.13) (Figure 3).
Discussion
To our best knowledge, this is the first report of a pa-
tient diagnosed with non-syndromic PRS associated with
a complex sSMC, which involved chromosomes 14 and
16 at breakpoints of 14q11.2 and 16p13.13, respectively.
Complex marker chromosome is one of the subgroups
of sSMC which consists of chromosomal material de-
rived from more than one chromosome and mostly as-
sociates with adverse clinical consequence [13]. Our
patient is the second report case of a complex sSMC in-
volving both chromosomes 14 and 16. However, the pre-
viously reported case involving both chromosomes 14
and 16 was der(14)t(14;16)(q12;q21), and the clinical fea-
tures showed bilateral equinovarus, overlapping fingers,
and intrauterine growth retardation, which were all dif-
ferent from the present case except the bilateral equino-
varus [14]. Chromosomal anomalies are the third most
common etiology in patients with PRS, occurring in 2%
of all PRS cases [15]. Translocations involving 17q23-
q25 are considered to be critical chromosomal regions
that may be responsible for PRS based on sporadic case
reports with t(2;17)(q23.3;q24.3), t(2;17)(q32;q24), t(5;17)
(q15;q24), t(2;17)(q24.1;q24.3), and t(13;17)(q22.1;q23.3)
[1,16,17]. The gene SOX9, located at chromosome 17q24
which was disrupted by translocation, was suggested to
be responsible for non-syndromic PRS based on prior
gene expression studies [16,17]. The sporadic cases with
deletion of 2q32.3-q33.2, 4q25-q27, 4qter, 11q21-q23,
16q12.1-q13, and 22q12.2, and the duplication of 1q12-
q25, 1q23.1-q31.1, 2q13-q21, 3q2, and 14qter were also
reported in patients with PRS [1,4,18,19].
To investigate whether the duplicated 14q11.2 and
pter-16p13.13 regions played a role in PRS development,
all cases with comparable chromosome 14q and 16p du-
plication documented in the sSMC database [20] and
PubMed were reviewed. A total of ten cases with sSMC
at the breakpoint of 14q11.2 were identified in the data-
base [20] (Table 1). In these ten sSMC cases, cytogeneti-
cally, three of them had ring-shaped sSMCs (cases 4, 7,
and 8), three of them had minute-shaped sSMCs (cases
3, 9, and 10), two of them were dicentric (cases 1 and 2),
and the remaining two were inverted duplicated sSMCs
(cases 5 and 6). Mosaicism was presented in three cases
(cases 2, 3, and 8). The identification and characterization
methods of sSMCs included FISH, array CGH, and multi-
plex ligation-dependent probe amplification (MLPA). Six
cases were characterized by FISH methods including
cen-FISH, multiplex fluorescence in situ hybridization
(M-FISH), and various FISH probes (cases 1, 2, 3, 5, 8, and 9).
Figure 1 Karyotype result. G-banding revealed a karyotype 47, XY, +mar in all studied cells. The marker is highlighted by an arrow.
Figure 2 Result of the array CGH genotyping (GRCh36/hg18). (A) The sSMC of the patient characterized after array CGH covering 3.8 Mb
[arr 14q11.2(19,694,999-23,534,999) × 3] in chromosome 14. (B) The sSMC of the patient characterized after array CGH covering 11.8 Mb [arr 16pterp13.13
(14,999-11,834,999) × 3] in chromosome 16.
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Figure 3 Confirmatory FISH result. Confirmatory FISH of this sSMC
using centromere probe 14/22 (red) and TelVysion 16p (green)
specific for 16pter revealed five distinct red signals and three distinct
green signals confirming the origins of the sSMC. The marker is
highlighted by a white arrow.
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10). Multiplex ligation-dependent probe amplification was
performed on one case (case 6). One case was studied by
routine cytogenetic method (case 4). Clinically, cases 1, 2,
3, and 4 were reported to have normal phenotype. Case 5
and 6 were detected prenatally, with maternal inherited
inv dup(14)(q11.2). The pregnancy outcomes of case 5
and 6 were unknown, but mothers with same markers
were phenotypically normal. Thus, these six sSMCs do
not appear to have any clinical phenotype. The remaining
four cases, cases 7–10, showed variable clinical features.
Both case 7 and case 8 had ring chromosome with similar
breakpoints, r(14)(::p11.2→ q11.2::), however, the pheno-
types of these two cases were different. Case 7 had hypo-
gonadotopic hypogonadism, precocious puberty, small
hands, scoliosis, hypogonadism, and moderate mental de-
velopment delay, whereas case 8 only had dwarfism. As
expected, the consequences of ring marker chromosomes
were more complicated than other types of chromosomal
anomalies. Clinical phenotypes of ring chromosomes are
influenced by the size of the ring chromosome, rearrange-
ment of the ring chromosome due to ring instability, and
epigenetic factors caused by the circular architecture of
ring chromosomes [21]. It is evident that because there
were no overlapping phenotypes observed in cases 7 and
8, the clinical features were more likely related to ring
chromosome complicated consequences other than dos-
age effects of the duplicated regions. Case 9 had a minutechromosome derived from chromosome 14 complicated
with maternal UPD 14 and the patient had classical fea-
tures of maternal UPD 14, i.e. microcephaly, developmen-
tal delay, small stature, and hypotonia [22]. In case 10,
the patient only showed dysmorphic features. None of the
above reported cases had micrognathia, which was the pri-
mary event in PRS, suggesting that chromosome 14q11.2
duplication was unlikely to be responsible for the PRS
of our patient. Thus, chromosome 14q11.2 duplication
does not appear to be a severe pathogenic copy number
variation (CNV).
Chromosomal 16p is a common region for chromo-
somal rearrangements. Twenty-seven cases with pure
16p duplication characterized by array CGH or single
nucleotide polymorphism (SNP) array assay were found
in the literature and summarized in Table 2. Cytogeneti-
cally, twenty-six of them only involved band 16p13.3,
and the remaining one involved the 16p13.2-16pter re-
gion, whereas our case had a gain of 16p13.13-pter re-
gion (Figure 4). Phenotypically, close review identified
that in those twenty-seven cases, plus our case, twenty-
four of them had documented mandible development
and ten had micrognathia. The remaining four cases did
not have mandible developmental description (Table 2,
Figure 4). Based on current evidence, genomic microdu-
plicaion syndromes are frequently associated with incom-
plete penetrance and variable expression of phenotypes
[23]. In this cohort, ten out of twenty-four cases developed
micrognathia, indicating that chromosome 16p duplica-
tion is the cause of micrognathia, although the penetrance
was not complete. Etiologically, any factors resulting in
micrognathia in the early development could lead to PRS.
However, abnormal mandible growth early in develop-
ment does not instantly trigger the subsequent events,
such as cleft palate and/or glossoptosis. Some patients
might have the isolated small jaw or cleft palate without
the airway obstruction. Thus, in those patients who had
micrognathia, a smaller number of patients with cleft pal-
ate was observed, and only our patient had both cleft palate
and airway obstruction and was diagnosed with PRS. Previ-
ous studies documented that genetically, the specific gene
mutations, translocations, deletions, and duplications in-
volving multiple chromosomes related to PRS [1,4,16-19].
This evidence supported that PRS was a disease with gen-
etic heterogeneity. The chromosomal or genetic anomalies
were the initiating events of the whole PRS sequence.
Therefore, the duplicated 16p13.13-pter region likely led to
micrognathia and was also responsible for the PRS pheno-
type of our patient. At this time, the underlying causes pro-
moting small mandible into PRS are not clarified.
Molecularly, in these nine cases, plus our case, with
micrognathia, the array data showed that the size of the
duplicated segments ranged from 0.409 Mb to 11.8 Mb.
The overlapping region of those ten cases was approximately
Table 1 Clinical manifestations of the patients with sSMCs including region 14q11.2
Case # (no. in database) de novo/inherited Test methods Final result of the sSMC Clinical symptoms
1 (14-O-q11.2/1-1) de novo cep 14/22; cep 15; cep 13/21 47,XY,+dic(14;15)(14pter→ 14q11.2::15q11.1→ 15pter) [100%] Normal
2 (14-O-q11.2/2-1) n.a. M-FISH; subcenM-FISH 47,XY,+dic(14)(:p11.1→ q11.1::p11.1→ q11.2:)[15]/46,XY[10] Normal
3 (14-O-q11.2/3-1) n.a. acrocenM-FISH; subcenM-FISH 47,XX,+min(14)(pter→ q11.2:)[40]/46,XX[60] Normal female, fertility problems
4 (14-O-q11.2/4-1) n.a. n.a. 47,XY,+r(14)(::p11.2→ q11.2::)[100%] Normal male, fertility problems - oligospermia
5 (14-O-q11.2/5-1) maternal acrocenM-FISH; subcenM-FISH;
Array CGH
47,XY,+inv dup(14)(q11.2)[100%](1.79 MB) Pregnancy outcome unknown but mother
clinically normal
6 (14-O-q11.2/5-2) maternal MLPA 47,XY,+inv dup(14)(q11.2)[100%] Abnormal first trimester screening; mother normal
7 (14-W-q11.2/2-1) n.a. Array CGH 47,XY,+r(14)(::p11.2→ q11.2::)[100%]
(array-CGH data not available)
Hypogonadotopic hypogonadism, moderate
mental developmental delay, precocious puberty,
small hands, scoliosis
8 (14-W-q11.2/2-2) n.a. cenM-FISH; subcenM-FISH 47,XY,+r(14)(::p11.?2→ q11.2::)[14]/46,XY[16] Normal, apart from dwarphism
9 (14-U-16) de novo Different FISH-probes;
subcenM-FISH; UPD-test
47,XY,+min(14)(pter → q11.1 ~ q11.2:)[100%]
maternal UPD 14
No mental retardation; at 4 y all values <3rd centile
(height 85 cm, weight 11.5 kg, OFC 47,5 cm);
microcephaly, simian crease, developmental delay,
small stature, hypotonic

















Table 2 Clinical manifestations of the patients with partial 16p duplication



























Mental retardation + + + + + + - + + + + + + +
Eye anomalies + + + + + + + + + + - + +




+ + + + + + + + - + - + +
Short palpebral
fissures
+ + + + - - + + - - - + +
Nose anomalies - + + + + + + + + + + + + + +
Cleft palate - - - - - - - - + - - - + + -
Ears anomalies - + + + + + + + + + + + + +




Micrognathia - - + - - + - - + - - - + -
Bilateral inguinal
hernia
+ - + - + + - - - + - -
Hand anomalies + + + + + + + + + + + + + +
Foot abnormality + - + + + - + + - + +
Congenital
heart disease
- - + + + + - - - + - - +
Break point (Mb) 3.7-3.9 3.6-3.9 3.7-4.1 3.6-4.0 3.6-4.0 3.6-4.2 2.6-4.5 3.5-4.7 3.7-4.9 2.8-4.1 3.0-4.3 2.6-3.9 3.7-5.2 2.6-4.7 2.9-5.0
















Table 2 Clinical manifestations of the patients with partial 16p duplication (Continued)


















Mental retardation + + + + + + - + + + + +
Eye anomalies + + + + + + + + + + + +




- - - + + - + + + + + +
Short palpebral
fissures
+ + - + - + + + + + + +
Nose anomalies + + - + - - - + + + + -
Cleft palate - - - - - - - + + + +
Ears anomalies + + - + + + - + + + + + -
Microcephaly + - + + + + -
Long face/
round face
+ + + + -
Micrognathia - + + - - - + + + +
Bilateral inguinal
hernia
- - - - - - + - +
Hand anomalies + + + + + + + - + + + +
Foot abnormality + + + - + + + + + + - + +
Congenital
heart disease
+ - - - - - + - - - - -
Break point (Mb) 2.6-5.0 2.6-5.0 2.8-5.3 2.7-5.2 3.5-6.1 2.9-5.7 1.8-4.6 0.9-3.8 0.9-3.9 1.3-4.8 1.3-4.8 0-8.6 0-11.8
















Figure 4 Map of the chromosome 16p duplicated region. The order of the cases follows the same order in Table 2.
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http://www.molecularcytogenetics.org/content/7/1/760.409 Mb in size (Table 2, Figure 4). There were three
genes mapped in this region including TRAP1, CREBBP,
and ADCY9. The mutant CREBBP gene (OMIM 600140),
or microdeletion of chromosome 16p13.3 including the
CREBBP gene, is responsible for the development of the
Rubinstein–Taybi syndrome (OMIM 180849) [32]. The
significance of both TRAP1 (OMIM 606219) and ADCY9
(OMIM 603302) were unknown based on current evidence.
Previous studies suggested that the CREBBP gene was
dosage sensitive, and also responsible for the phenotype
of chromosome 16p13.3 duplication syndrome [24-26].
Chromosome 16p13.3 duplication syndrome was due to
the duplication of chromosome 16p13.3 encompassing theCREBBP gene and characterized by frequent clinical find-
ings such as mild to middle intellectual disability, facial
dysmorphism, anomalies of the extremities, and occa-
sional developmental defect of the eyes, palate, genitalia,
and heart (OMIM 613458). Both the genotype and pheno-
type of our case overlapped with chromosome 16p13.3
duplication syndrome, suggesting that the duplication of
16p13.3 was the pathogenic CNV in our case, and the
CREBBP gene was the most critical candidate gene re-
sponsible for the phenotype of our patient. On the other
hand, the overlapping region of all twenty-seven cases
plus our case was 163 Kb in size (chr16:3,701,913-
3,864,938). There were three genes mapped in this region
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DNASE1 gene (OMIM 125505) was susceptible to systemic
lupus erythematosus, which had no overlapping phenotype
with presented cases. The significance of TRAP1 (OMIM
606219) was unknown. The CREBBP gene was the most
critical gene responsible for the phenotype based on
current evidence [24-26]. For the twenty-eight cases listed
in Table 2, all of them encompassed the CREBBP gene, and
only ten of them had micrognathia. Thus, our literature re-
view suggested that the duplicated CREBBP gene was asso-
ciated with incomplete penetrance regarding the mandible
development anomalies.
Conclusion
In conclusion, our data and literature review suggest that
the duplicated chromosome segment 16p13.3 may be re-
sponsible for the phenotype of the case presented and
also may be a candidate locus of non-syndromic PRS. It
is also noteworthy that the duplicated CREBBP gene was
associated with incomplete penetrance regarding the
mandible development anomalies. Further studies of simi-
lar cases are needed to support our findings.
Materials and methods
At the age of two months, the proband was referred to
us for cytogenetic evaluation. Cultures of the patient’s
peripheral blood were established and harvested accord-
ing to our standard laboratory protocols. Chromosome
preparations were treated with trypsin and stained with
Giemsa. A total of 21 metaphase cells were analyzed at
550-band resolution level. The karyotypes were de-
scribed according to the guideline of An International
System for Human Cytogenetic Nomenclature [33]. The
parents declined to undergo chromosomal analysis.
A subsequent array-comparative genomic hybridization
(array CGH) test was performed to determine the
chromosomal origin of the sSMC, as well as other possible
chromosome abnormalities which may have been missed
by routine G-banded chromosomal analysis. Genomic
DNA was extracted from the patient’s peripheral white
blood cells using Nucleic Acid Isolation System (Quick-
Gene-610 L, FUJIFILM Corporation, Tokyo, Japan) ac-
cording to the manufacturer’s protocols. Human reference
genomic DNA was purchased from Promega (Promega
Corporation, Madison, WI, USA). The patient’s DNA and
the purchased reference DNA were labeled with either
cyanine 3 (Cy-3) or cyanine 5 (Cy-5) by random priming
(Trilink Biotechnologies, San Diego, CA, USA). These
samples were subsequently hybridized to a NimbleGen
high-capacity 3 × 720 K oligo microarray chip (Roche/
NimbleGen System Inc., Madison, WI, USA) by incubat-
ing in a MAUI Hybridization System (BioMicro Systems,
Salt Lake City, UT, USA) for 40 hours according to
NimbleGen’s CGH protocols. The array was scanned at532 nm and 635 nm using the GenePix scanner (Molecu-
lar Devices, Sunnyvale, CA, USA). NimbleScan and Sig-
nalMap (NimbleGen System Inc, Madison, WI, USA)
were applied for data analysis.
To verify array CGH findings, fluorescence in situ
hybridization (FISH) was performed using the meta-
phase cells from the cell pellet. Two probes, the combin-
ation centromeric probe 14/22 and the TelVysion 16p
probe specific for the terminal end of 16p (purchased
from Abbott Corporation, Abbott Park, IL, USA) were
used. Metaphase FISH analyses were performed accord-
ing to our standard laboratory procedures. A total of 50
metaphase cells were analyzed.
Consent
Since the patient information is completely de-identified
and samples were received following the standard of care
clinical evaluation, no IRB/consent is necessary based on
the policy of the University of Oklahoma.
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